Literature DB >> 2595338

Activity and severity of rheumatoid arthritis in Hannover/FRG and in one regional referral center.

A Wasmus1, P Kindel, S Mattussek, H H Raspe.   

Abstract

Between November 1984 and July 1988 a total of 8044 randomly selected German residents of the city of Hannover/FRG, aged 25 to 74, have been screened for rheumatic complaints by means of a postal questionnaire. An average 87% of the probands contacted returned completed questionnaires. Respondents with a "positive" questionnaire, i.e. suggestive of the existence of an inflammatory joint disease were invited for a rheumatological examination at the Hannover Medical School. 72% participated. 45 of a total of 1291 participants were identified as suffering from active or inactive, mostly rheumatoid arthritis. This yields a minimum prevalence of 0.56% (+/- 0.19%). The true prevalence is estimated to be 0.91% (99%-confidence interval 0.64-1.18). In 1985 and 1986 103 German RA sufferers aged 25 to 74, all citizens of Hannover, were referred to our outpatient rheumatology clinic for a first consultation. A comparison between the two groups revealed a higher disease activity in terms of "objective" criteria (joint swellings, ESR, rheumatoid factor) in the group of the referred patients as opposed to RA suffers from the community. Both groups were comparable in respect to "subjective" symptoms (morning stiffness, joint pain, pain intensity), functional capacity and degree of erosive joint lesions. The rheumatological outpatient clinic at the Hannover Medical School, providing the only specialized service in the region, actually covers less than 20% of all RA sufferers within the municipal area of Hannover and less than 50% of those with a "classical" RA according to the ARA-criteria.

Entities:  

Mesh:

Year:  1989        PMID: 2595338     DOI: 10.3109/03009748909092611

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  9 in total

1.  [Differences in chronic back pain and joint disorders among health insurance funds : Results of a cross-sectional study based on the data of the Socioeconomic Panel from 2013].

Authors:  A Luque Ramos; F Hoffmann
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

2.  [How frequent are musculoskeletal diseases in Germany?].

Authors:  A Zink; K Albrecht
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

3.  [Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg].

Authors:  A Strahl; O Schneider; J Frankenhauser-Mannuß; S Knapstein; C Hermann; B Lembeck; H-M Lorenz; W Rüther; J Flechtenmacher
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

4.  Statistical identification of syndromes feature and structure of disease of western medicine based on general latent structure model.

Authors:  Wei Yang; Dan-Hui Yi; Yan-Ming Xie; Feng Tian
Journal:  Chin J Integr Med       Date:  2012-07-19       Impact factor: 1.978

5.  [Healthcare research in rheumatology. Current state].

Authors:  A Zink
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

6.  [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].

Authors:  S Hense; A Luque Ramos; J Callhoff; K Albrecht; A Zink; F Hoffmann
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

7.  [Is the prevalence of rheumatoid arthritis truly on the rise?]

Authors:  Katinka Albrecht; Johanna Callhoff; Anja Strangfeld
Journal:  Z Rheumatol       Date:  2022-03-31       Impact factor: 1.372

8.  [Frequencies of musculoskeletal symptoms and disorders in the population-based German National Cohort (GNC)].

Authors:  Carsten Oliver Schmidt; Klaus-Peter Günther; Jens Goronzy; Katinka Albrecht; Jean-François Chenot; Johanna Callhoff; Adrian Richter; Richard Kasch; Wolfgang Ahrens; Heiko Becher; Klaus Berger; Hermann Brenner; Beate Fischer; Claus-Werner Franzke; Wolfgang Hoffmann; Bernd Holleczek; Lina Jaeschke; Carsten Jenning; Karl-Heinz Jöckel; Rudolf Kaaks; Thomas Keil; Alexander Kluttig; Gérard Krause; Oliver Kuß; Michael Leitzmann; Wolfgang Lieb; Jakob Linseisen; Markus Löffler; Claudia Meinke-Franze; Christa Meisinger; Karin B Michels; Rafael Mikolajczyk; Nadia Obi; Annette Peters; Tobias Pischon; Tamara Schikowski; Sabine Schipf; Christof Specker; Henry Völzke; Kerstin Wirkner; Angela Zink; Oliver Sander
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-04       Impact factor: 1.513

9.  Cost per responder of TNF-α therapies in Germany.

Authors:  Christian Gissel; Holger Repp
Journal:  Clin Rheumatol       Date:  2013-07-23       Impact factor: 2.980

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.